Literature DB >> 8324651

Interleukin-4 and cancer therapy.

R K Puri1, J P Siegel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8324651     DOI: 10.3109/07357909309018879

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  8 in total

1.  Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin.

Authors:  S R Husain; P Gill; R J Kreitman; I Pastan; R K Puri
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

2.  Clinical development of experimental therapies for malignant glioma.

Authors:  Nikolai G Rainov; Volkmar Heidecke
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

3.  Tumor angiogenesis: insights and innovations.

Authors:  Fernando Nussenbaum; Ira M Herman
Journal:  J Oncol       Date:  2010-04-26       Impact factor: 4.375

Review 4.  Immunotoxin therapy for CNS tumor.

Authors:  Edward Rustamzadeh; Walter C Low; Daniel A Vallera; Walter A Hall
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

Review 5.  Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy.

Authors:  Mariko Kawakami; Koji Kawakami; Raj K Puri
Journal:  J Neurooncol       Date:  2003-10       Impact factor: 4.130

6.  Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.

Authors:  G G Hillman; R K Puri; M A Kukuruga; J E Pontes; G P Haas
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

7.  Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions.

Authors:  O Prokopchuk; Y Liu; D Henne-Bruns; M Kornmann
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

8.  Inhibition of angiogenesis by interleukin 4.

Authors:  O V Volpert; T Fong; A E Koch; J D Peterson; C Waltenbaugh; R I Tepper; N P Bouck
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.